SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
27-Aug-24 8:00 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 23-Aug-24 | Private Purchase | 500,000 | $0.02 | $10,000.00 | < 1% 115.7M to 116.2M | |
30-Jun-23 9:25 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 29-Jun-23 | Purchase | 425,000 | $0.02 | $8,925.00 | < 1% 115.27M to 115.7M | |
30-Jun-23 9:25 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 28-Jun-23 | Private Purchase | 75,000 | $0.03 | $1,950.00 | < 1% 115.2M to 115.27M | |
20-Jun-23 12:00 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 16-Jun-23 | Private Purchase | 100,000 | $0.03 | $2,600.00 | < 1% 115.1M to 115.2M | |
16-Jun-23 12:00 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 14-Jun-23 | Private Purchase | 400,000 | $0.03 | $13,040.00 | < 1% 114.7M to 115.1M | |
31-May-23 9:39 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 26-May-23 | Private Purchase | 126,888 | $0.03 | $4,326.88 | < 1% 114.57M to 114.7M | |
02-May-23 10:00 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 02-May-23 | Private Purchase | 100,000 | $0.05 | $4,500.00 | < 1% 114.47M to 114.57M | |
07-Dec-22 8:00 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 06-Dec-22 | Private Purchase | 120,000 | $0.05 | $6,000.00 | < 1% 114.09M to 114.21M | |
25-Nov-22 9:00 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 22-Nov-22 | Private Purchase | 70,000 | $0.08 | $5,600.00 | < 1% 114.02M to 114.09M | |
28-Sep-22 9:15 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 26-Sep-22 | Private Purchase | 20,000 | $0.07 | $1,360.00 | < 1% 114.0M to 114.02M | |
29-Aug-22 9:15 AM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 25-Aug-22 | Private Purchase | 80,000 | $0.08 | $6,560.00 | < 1% 113.92M to 114.0M | |
16-Jul-21 5:37 PM View: | Shah Amit B. CHIEF FINANCIAL OFFICER | Oxigene Inc. (OTLC) | 08-Jul-21 | Grant | 298,837 | -- | -- | 498% 60.0K to 358.84K | |
16-Jul-21 5:38 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 08-Jul-21 | Grant | 259,302 | -- | -- | < 1% 113.92M to 114.18M | |
16-Jul-21 5:35 PM View: | Saund Saran CHIEF BUSINESS OFFICER | Oxigene Inc. (OTLC) | 08-Jul-21 | Grant | 102,519 | -- | -- | < 1% 16.35M to 16.46M | |
16-Jul-21 5:39 PM View: | Maida Anthony E III CHIEF CLINICAL OFFICER Director | Oxigene Inc. (OTLC) | 31-Mar-21 | Conversion | 938,646 | -- | -- | 472% 198.66K to 1.14M | |
16-Jul-21 5:37 PM View: | King Steven W Director | Oxigene Inc. (OTLC) | 31-Mar-21 | Conversion | 3,291,720 | -- | -- | 8456% 38.93K to 3.33M | |
16-Jul-21 5:38 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 31-Mar-21 | Conversion | 74,455,696 | -- | -- | 373% 19.94M to 94.4M | |
16-Jul-21 5:35 PM View: | Saund Saran CHIEF BUSINESS OFFICER | Oxigene Inc. (OTLC) | 31-Mar-21 | Conversion | 16,355,000 | -- | -- | 100% 0 to 16.36M | |
16-Jul-21 5:38 PM View: | Trieu Vuong CHAIRMAN AND CEO Director 10% Owner | Oxigene Inc. (OTLC) | 31-Mar-21 | Conversion | 19,521,200 | -- | -- | 21% 94.4M to 113.92M | |
24-Nov-20 5:30 PM View: | Shah Amit B. CHIEF FINANCIAL OFFICER | Oxigene Inc. (OTLC) | 24-Nov-20 | Purchase | 8,220 | $0.19 | $1,561.80 | 16% 51.78K to 60.0K | |
24-Nov-20 5:30 PM View: | Shah Amit B. CHIEF FINANCIAL OFFICER | Oxigene Inc. (OTLC) | 23-Nov-20 | Purchase | 20,088 | $0.19 | $3,816.72 | 63% 31.69K to 51.78K | |
24-Nov-20 5:30 PM View: | Shah Amit B. CHIEF FINANCIAL OFFICER | Oxigene Inc. (OTLC) | 20-Nov-20 | Private Purchase | 31,692 | $0.19 | $6,179.94 | 100% 0 to 31.69K | |
23-Nov-20 3:01 PM View: | Trieu Vuong CHIEF EXECUTIVE OFFICER | Oxigene Inc. (OTLC) | 19-Nov-20 | Private Purchase | 50,500 | $0.19 | $9,595.00 | < 1% 19.89M to 19.94M | |
23-Nov-20 3:01 PM View: | Park Chulho CHIEF TECHNOLOGY OFFICER | Oxigene Inc. (OTLC) | 19-Nov-20 | Private Purchase | 22,173 | $0.18 | $4,097.57 | < 1% 2.81M to 2.83M | |
27-Mar-20 5:49 PM View: | Trieu Vuong CHIEF EXECUTIVE OFFICER | Oxigene Inc. (OTLC) | 26-Mar-20 | Private Purchase | 3,000 | $0.12 | $360.00 | < 1% 19.89M to 19.89M | |
16-Apr-18 4:23 PM View: | Schwieterman William D President and CEO Director | Oxigene Inc. (OTLC) | 12-Apr-18 | Purchase | 625,000 | -- | -- | 83668% 0.75K to 625.75K | |
16-Apr-18 4:24 PM View: | Reynolds Donald Rogers Director | Oxigene Inc. (OTLC) | 12-Apr-18 | Purchase | 250,000 | -- | -- | 833% 30.0K to 280.0K | |
16-Apr-18 4:22 PM View: | Loar Matthew M Chief Financial Officer | Oxigene Inc. (OTLC) | 12-Apr-18 | Purchase | 250,000 | -- | -- | 500% 50.0K to 300.0K | |
20-Dec-16 4:15 PM View: | Reynolds Donald Rogers Director | Oxigene Inc. (OTLC) | 16-Dec-16 | Market Purchase | 30,000 | $0.35 | $10,422.80 | 100% 0 to 30.0K | 101% |
07-Jul-14 8:16 AM View: | McMahon Gerald Phd Director | Oxigene Inc. (OTLC) | 02-Jul-14 | Grant | 3,847 | -- | -- | 26% 14.76K to 18.61K | |
06-Jan-14 4:47 PM View: | McMahon Gerald Phd Director | Oxigene Inc. (OTLC) | 02-Jan-14 | Grant | 3,584 | -- | -- | 32% 11.18K to 14.76K | |
09-Aug-13 6:16 PM View: | Langecker Peter Chief Executive Officer Director | Oxigene Inc. (OTLC) | 08-Aug-13 | Grant | 72,993 | -- | -- | 1460% 5.0K to 77.99K | |
02-Jul-13 4:58 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 01-Jul-13 | Grant | 3,703 | -- | -- | 73% 5.06K to 8.76K | |
02-Jul-13 4:58 PM View: | McMahon Gerald Phd Director | Oxigene Inc. (OTLC) | 01-Jul-13 | Grant | 7,407 | -- | -- | 196% 3.77K to 11.18K | |
01-Jul-13 12:31 PM View: | Langecker Peter Chief Executive Officer Director | Oxigene Inc. (OTLC) | 28-Jun-13 | Market Purchase | 3,000 | $2.75 | $8,250.00 | 150% 2.0K to 5.0K | (74%) |
26-Jun-13 6:06 PM View: | Langecker Peter Chief Executive Officer Director | Oxigene Inc. (OTLC) | 25-Jun-13 | Market Purchase | 2,000 | $2.79 | $5,572.00 | 100% 0 to 2.0K | (74%) |
03-Jan-13 5:29 PM View: | McMahon Gerald Phd Director | Oxigene Inc. (OTLC) | 02-Jan-13 | Grant | 3,773 | -- | -- | 100% 0 to 3.77K | |
03-Jan-13 5:30 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 02-Jan-13 | Grant | 1,886 | -- | -- | 59% 3.17K to 5.06K | |
03-Jul-12 9:07 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 02-Jul-12 | Grant | 18,148 | -- | -- | 91% 19.91K to 38.06K | |
04-Jan-12 5:05 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 02-Jan-12 | Grant | 10,101 | -- | -- | 103% 9.81K to 19.91K | |
02-Nov-11 4:15 PM View: | Wood Alastair Jj Director | Oxigene Inc. (OTLC) | 31-Oct-11 | Grant | 12,121 | -- | -- | 211% 5.75K to 17.87K | |
02-Nov-11 4:14 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 31-Oct-11 | Grant | 6,061 | -- | -- | 162% 3.75K to 9.81K | |
04-Jan-11 9:50 PM View: | Shiebler William N Director | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 9% 292.0K to 317.0K | (99%) |
04-Jan-11 9:48 PM View: | Fickling Roy H Director | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 14% 177.85K to 202.85K | (99%) |
04-Jan-11 9:50 PM View: | Wood Alastair Jj Director | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 28% 90.0K to 115.0K | (99%) |
04-Jan-11 9:49 PM View: | Howson Tamar D Director | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 50% 50.0K to 75.0K | (99%) |
04-Jan-11 9:50 PM View: | Schwieterman William D Director | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 16% 154.21K to 179.21K | (99%) |
04-Jan-11 9:49 PM View: | Kessel Mark Director 10% Owner | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | < 1% 27.21M to 27.23M | (99%) |
06-Jul-10 9:10 PM View: | Shiebler William N Director | Oxigene Inc. (OTLC) | 01-Jul-10 | Grant Duplicate | 25,000 | $0.38 | $9,502.50 | 9% 267.0K to 292.0K | (99%) |
06-Jul-10 5:16 PM View: | Fickling Roy H Director | Oxigene Inc. (OTLC) | 01-Jul-10 | Grant | 25,000 | $0.38 | $9,502.50 | 16% 152.85K to 177.85K | (99%) |